We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+20.01%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$81.4M
AUM Growth
-$48.9M
Cap. Flow
-$56.7M
Cap. Flow %
-69.64%
Top 10 Hldgs %
76.08%
Holding
43
New
13
Increased
7
Reduced
7
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 25.5%
2 Materials 19.65%
3 Communication Services 12.54%
4 Technology 7.62%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
1
Linde
LIN
$237B
$14M 17.15%
65,190
+64,149
+6,162% +$12.9M
AGN
2
DELISTED
Allergan plc
AGN
$11.2M 13.71%
58,402
+10,000
+21% +$1.8M
ZAYO
3
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$10.2M 12.52%
294,221
+65,000
+28% +$2.23M
T icon
4
AT&T
T
$153B
$6.16M 7.56%
208,653
+45,741
+28% +$1.32M
TIF
5
DELISTED
Tiffany & Co.
TIF
$5.35M 6.57%
+40,000
New +$4.73M
WAIR
6
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$3.99M 4.91%
362,431
+192,722
+114% +$2.12M
CY
7
DELISTED
Cypress Semiconductor
CY
$3.62M 4.44%
155,000
+30,000
+24% +$702K
CZR
8
DELISTED
Caesars Entertainment Corporation
CZR
$3.1M 3.81%
+228,200
New +$2.89M
ATVI
9
DELISTED
Activision Blizzard
ATVI
$2.31M 2.83%
+38,798
New +$2.15M
INXN
10
DELISTED
Interxion Holding N.V.
INXN
$2.1M 2.57%
+25,000
New +$2.09M
BMY icon
11
Bristol-Myers Squibb
BMY
$123B
$2.03M 2.49%
31,589
-171,268
-84% -$9.81M
OMN
12
DELISTED
OMNOVA Solutions Inc.
OMN
$1.96M 2.41%
193,761
-150,000
-44% -$1.52M
SPOT icon
13
Spotify
SPOT
$101B
$1.95M 2.4%
+13,059
New +$1.79M
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
$1.83M 2.25%
+59,980
New +$1.57M
FIT
15
DELISTED
Fitbit, Inc. Class A common stock
FIT
$1.44M 1.77%
+219,100
New +$1.29M
MDCO
16
DELISTED
Medicines Co
MDCO
$1.27M 1.56%
+15,000
New +$1M
ASH icon
17
Ashland
ASH
$3.1B
$1.15M 1.41%
15,000
-110,645
-88% -$8.4M
TAK icon
18
Takeda Pharmaceutical
TAK
$54.4B
$1.05M 1.29%
53,092
-9,546
-15% -$183K
PACB icon
19
Pacific Biosciences
PACB
$419M
$1.02M 1.25%
198,743
FTSV
20
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$932K 1.14%
23,674
-69,508
-75% -$1.12M
KL
21
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$882K 1.08%
+20,000
New +$887K
AMGN icon
22
Amgen
AMGN
$197B
$850K 1.04%
3,526
-20,482
-85% -$4.51M
DPLO
23
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$800K 0.98%
+200,000
New +$939K
CTMX icon
24
CytomX Therapeutics
CTMX
$766M
$730K 0.9%
87,876
+33,811
+63% +$228K
QURE icon
25
uniQure
QURE
$2.73B
$717K 0.88%
+10,000
New +$549K

Similar funds

Exane Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Exane Asset Management held 43 positions worth $81.4M, down 38% from $130M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Exane Asset Management withdrew a net $56.7M in Q4 2019, closing 15 positions and reducing 7 holdings. Its most notable exit was Celgene Corp, an estimated $9.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 53% a quarter earlier, followed by Materials and Communication Services.

Against the trend, Exane Asset Management opened a new position in Tiffany & Co. worth $5.35M.

  • Exane Asset Management's largest Q4 2019 buy was Tiffany & Co.: 40,000 shares worth $5.35M.
  • Exane Asset Management added most to Linde in Q4 2019, an estimated $12.9M increase.
  • Exane Asset Management's biggest Q4 2019 reduction was Alcon, cutting an estimated $19.1M.
  • Exane Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $9.51M.
  • Exane Asset Management's ten largest holdings make up 76% of its $81.4M portfolio in Q4 2019.
  • Exane Asset Management opened 13 new positions and closed 15 in Q4 2019.
  • Exane Asset Management's portfolio value fell 38% quarter-over-quarter to $81.4M.

Based on Exane Asset Management's 13F filing for Q4 2019, filed 3 Feb 2020.